Compression Therapy Market Analysis

In terms of technology, the compression therapy market from the static compression therapy segment is anticipated to reach over USD 3.5 billion by 2032 due to the rising prevalence of vascular ailments and a surge in the number of deep vein thrombosis (DVT) patients. For instance, in the United States, DVT or pulmonary embolism (PE) affects as many as 900,000 people annually. Static compression therapy is a proven treatment option for DVT, resulting in the mounting demand for the therapy, which is expected to stimulate segment revenue.
 

By application, the varicose vein treatment segment held more than 36% revenue share in the compression therapy market in 2022 and is poised to exhibit a robust growth rate through 2032. The varicose vein is the most reported medical issue, causing significant morbidity and long-term medical expenses for the patient. Varicose veins are prevalent globally owing to the expanding geriatric population base, the current sedentary lifestyle, and the lack of physical exercise.
 

North America global compression therapy market held around 33% industry share in 2022 and is projected to generate lucrative gains by 2032 attributable to several factors, including an increase in the number of surgical operations, an increase in the frequency of venous diseases, and favorable government efforts. Moreover, the presence of major industry players and their ongoing efforts to develop cost-effective and innovative products is likely to stimulate the regional revenue share.